|
|
| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 50419-390 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | CAPSULE | 2019-07-26 | |
| 50419-391 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | CAPSULE | 2019-07-26 | |
| 50419-392 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | SOLUTION, CONCENTRATE | 2019-07-26 | |
| 50419-393 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | SOLUTION, CONCENTRATE | 2022-12-06 | |
| 71777-390 | VITRAKVI | LAROTRECTINIB | Loxo Oncology, Inc. | CAPSULE | 2018-11-26 | |
| 71777-391 | VITRAKVI | LAROTRECTINIB | Loxo Oncology, Inc. | CAPSULE | 2018-11-26 | |
| 71777-392 | VITRAKVI | LAROTRECTINIB | Loxo Oncology, Inc. | SOLUTION | 2018-11-26 |
Loading full table content...